Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

[1]  R. Singal,et al.  EGFR targeting of solid tumors. , 2007, Cancer control : journal of the Moffitt Cancer Center.

[2]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[3]  Hiroshi Suzuki,et al.  Expression of amphiregulin during the pre- and post-implantation period in the mouse reproductive tract. , 2006, Journal of reproduction and development.

[4]  A. Citri,et al.  EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.

[5]  R. Wanke,et al.  Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. , 2005, Endocrinology.

[6]  Ho-Yyoung Lee,et al.  Resistance to epidermal growth factor receptor-targeted therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[7]  Satoshi O. Suzuki,et al.  Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer , 2005, Clinical Cancer Research.

[8]  E. Mekada,et al.  Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.

[9]  David C. Lee,et al.  Novel Role for Amphiregulin in Protection from Liver Injury* , 2005, Journal of Biological Chemistry.

[10]  H. Lane,et al.  ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.

[11]  S. Miyamoto,et al.  Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer , 2005, British Journal of Cancer.

[12]  J. Baselga,et al.  Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  David C. Lee,et al.  Heparin-binding Epidermal Growth Factor-like Growth Factor Links Hepatocyte Priming with Cell Cycle Progression during Liver Regeneration* , 2005, Journal of Biological Chemistry.

[14]  V. Godfrey,et al.  Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage , 2004, Molecular and Cellular Biology.

[15]  M. Kai,et al.  Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy , 2004, Cancer Research.

[16]  S. Chan,et al.  Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle* , 2003, Journal of Biological Chemistry.

[17]  David C. Lee,et al.  Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.

[18]  Robert J Coffey,et al.  EGF receptor ligands. , 2003, Experimental cell research.

[19]  Masatsugu Hori,et al.  Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Coene,et al.  The role of heregulin‐α as a motility factor and amphiregulin as a growth factor in wound healing , 2002, The Journal of pathology.

[21]  S. Leach,et al.  Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. , 2002, Gastroenterology.

[22]  David C. Lee,et al.  Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. , 2001, Gastroenterology.

[23]  A. Schulze,et al.  Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.

[24]  Fiona M. Watt,et al.  The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.

[25]  David C. Lee,et al.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.

[26]  D. Stern,et al.  Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  S. Oldham,et al.  A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[28]  J. Abraham,et al.  Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. , 1995, Genes & development.

[29]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[30]  M. Klagsbrun,et al.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.

[31]  R. Coffey,et al.  Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. , 1995, Gastroenterology.

[32]  E. Nice,et al.  Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.

[33]  David C. Lee,et al.  TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.

[34]  T. Uchida,et al.  Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. , 1973, The Journal of biological chemistry.